Health Care/Hospital
3B Scientific Acquires Veterinary Simulator Industries
HAMBURG, Germany, Sept. 23, 2024 /PRNewswire/ -- 3B Scientific, a global leader in the manufacturing and marketing of medical and scientific educational products, announced today that it has acquired Veterinary Simulator Industries (VSI), a leading developer of veterinary simulation models. Foun...
2024-09-23 18:00
1458
Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Thailand
* XPOVIO® is the first and only approved XPO1 inhibitor in Thailand. * XPOVIO® has been approved for multiple indications in nine markets across the APAC region. Antengene has submitted a new drug application (NDA) for XPOVIO ® in Indonesia with approval expected in the second half of 2024. ...
2024-09-23 17:42
3446
WuXi Biologics Included in Hang Seng ESG 50 Index
HONG KONG, Sept. 23, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has been included in the Hang Seng ESG 50 Index, making it the only pharmaceutical company selected this...
2024-09-23 17:30
1190
Anytime Fitness Asia Opens 400th Club in Bangkok, Expanding Regional Presence
BANGKOK, Sept. 23, 2024 /PRNewswire/ -- Anytime Fitness Asia, the leading fitness franchise inSoutheast Asia, proudly announces the opening of its 400th club at Exchange Tower inBangkok, Thailand. This milestone represents a major achievement in the brand's ongoing growth and expansion across the...
2024-09-23 15:12
2001
Professor Luo Min Appointed as Chairman of Spine Neurocardiology Interdisciplinary Professional Committee in China to Promote Development of Innovative Heart Disease Treatments
BEIJING, Sept. 23, 2024 /PRNewswire/ -- Professor Luo Min, Doctor of Medicine (MD), from Beijing Yuhe Integrated Traditional Chinese and Western Medicine Rehabilitation Hospital, was recently appointed as the Chairman of the National Association of Health Industry and Enterprise Management (NAHIE...
2024-09-23 15:06
1114
FluoRok raises £7.7m ($9.8m) to transform the safety and sustainability of fluorochemical production
OXFORD, England, Sept. 23, 2024 /PRNewswire/ -- FluoRok, an Oxford-based start-up, has raised £7.7m to scale-up, manufacture and commercialise novel fluorochemical reagents and battery electrolyte salts. The oversubscribed round was led by BGF alongside Green Generation Fund and included battery ...
2024-09-23 15:00
1373
Nuance Pharma Announces Expansion of Bentrio License and Distribution Agreement with Altamira Therapeutics in East and South East Asia
* Nuance Pharma successfully launched Bentrio® nasal spray for protection against airborne particles inHong Kong and filed request for marketing authorization for Mainland China * Extension of Exclusive License and Distribution Agreement to include seven additional countries across East andS...
2024-09-23 15:00
1615
Clarivate and Relatable Healthcare Forge Strategic Partnership to Transform Medtech Sales Contracting Process
Clarivate Medtech Intelligence and Relatable software enhance product data management and competitive conversion efficiency for medtech sales, contracting and pricing teams LONDON, Sept. 23, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence...
2024-09-23 15:00
1234
First Sino-Australian Cross-Border E-Commerce Development Conference Concludes Successfully in Sydney; Witsbb Wins Star of the Year Award
SYDNEY, Sept. 23, 2024 /PRNewswire/ -- On September 9, the first Sino-Australian Cross-Border E-Commerce Development Summit, hosted by Douyin Global Shopping and co-organized by the Australian Trade and Investment Commission (Austrade) and the Australia China Business Council (ACBC), was grandly...
2024-09-23 14:03
1408
Huawei Launches Medical Technology Digitalization 2.0 Solution, Facilitating Precision Healthcare with AI
SHANGHAI, Sept. 23, 2024 /PRNewswire/ -- At HUAWEI CONNECT 2024, Huawei teamed up with partners to launch the Medical Technology Digitalization 2.0 Solution at the healthcare session namedEnhancing Inclusivity to Amplify Healthcare Intelligence. This solution implements AI-assisted diagnosis and ...
2024-09-23 12:10
4291
Telix to Acquire RLS to Expand North American Manufacturing and Distribution Platform
MELBOURNE, Australia, INDIANAPOLIS and LAKE MARY, Fla., Sept. 23, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RLS (USA) Inc. (RLS, RLS Radiopharmacies), America's only Joint Commission-accredited radiopharmacy network distributing PET[1], SPECT[2] and th...
2024-09-23 07:38
1613
European Wellness and Jilin Hanxing Group Forge Strategic Partnership to Advance Global Wellness Initiatives
KOTA KINABALU, SABAH, Malaysia, Sept. 21, 2024 /PRNewswire/ -- In a landmark move set to reshape the landscape of global wellness and regenerative medicine, European Wellness Biomedical Group and Jilin Hanxing Group have signed a pivotal Strategic Cooperation Agreement. The signing ceremony took ...
2024-09-21 23:10
4013
Summit of Whose Future? Girls Have the Answers: Leaders Must Listen
Young Women Activists Launch "What Girls Want," Demand World Leaders Put Girls at the Center of Summit of the Future NEW YORK, Sept. 21, 2024 /PRNewswire/ -- Today in New York, more than 50 young women from around the world – including Nobel Prize Laureate Malala Yousafzai – gathered to take go...
2024-09-21 21:30
2376
Gymera Reveal A Breakthrough in Smart Home Fitness and Elderly Wellness Solution at Hong Kong Global Sources Consumer Electronics Show 2024
SHENZHEN, China, Sept. 21, 2024 /PRNewswire/ -- In today's fast-paced world, maintaining health and vitality has become increasingly important, especially in home fitness and eldercare scenarios. Gymera proudly introduces the MA-001, a full-featured smart fitness mirror that perfectly integrates ...
2024-09-21 18:32
3598
Henlius Receives Positive CHMP Opinion for HANSIZHUANG as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
* HANSIZHUANG (serplulimab) is the world's first anti-PD-1 mAb for first-line treatment of ES- SCLC - * HANSIZHUANG (serplulimab) is expected to become the first and only anti-PD-1 monoclonal antibody available inEurope for first-line treatment of ES- SCLC - * HANSIZHUANG (serplulimab) ha...
2024-09-21 13:42
4253
European Wellness Unveils Premier Medical Wellness Center in Kota Kinabalu, Sabah: A Landmark in Global Healthcare
KOTA KINABALU, Malaysia, Sept. 21, 2024 /PRNewswire/ -- European Wellness, a global leader in regenerative medicine and integrated healthcare, has inaugurated its latest and most advanced facility, the European Wellness New Premier Center, in Kota Kinabalu,Sabah. This landmark 60,000 square-foot ...
2024-09-21 09:00
4845
Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results
YANGZHOU, China, Sept. 20, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries inChina, today reported its unaudited ...
2024-09-21 05:30
6911
Biosyngen Best-in-Class Next-Generation Tumor-Infiltrating Lymphocyte (TIL) Technology Debuts on ESMO 2024 Annual Meeting
BARCELONA, Spain, Sept. 20, 2024 /PRNewswire/ -- The highly anticipated 2024 European Society for Medical Oncology (ESMO) Annual Congress has taken place fromSeptember 13 to 17 in Barcelona, Spain. As one of the most influential annual gatherings in oncology, this congress brings together leading...
2024-09-20 20:30
1446
Kangpu Completed Bridging Clinical Study of KPG-818 in China
HEFEI, China, Sept. 20, 2024 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company based inHefei, China, announced today that the Company has successfully completed a bridging clinical study of KPG-818 in healthy subjects inChina. The randomized, double-blind, placebo-controlled,...
2024-09-20 20:00
1965
CD (Suzhou) Biopharma Announces FDA Clearance for Phase I Clinical Trial of CD-001
SUZHOU, China, Sept. 20, 2024 /PRNewswire/ -- CD (Suzhou) Biopharma
2024-09-20 16:28
1561
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5216
